IMMUNITAIRE Trademark

Trademark Overview


On Friday, December 10, 2021, a trademark application was filed for IMMUNITAIRE with the United States Patent and Trademark Office. The USPTO has given the IMMUNITAIRE trademark a serial number of 97166606. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, July 18, 2023. This trademark is owned by Immunitaire Therapeutics, LLC. The IMMUNITAIRE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals and pharmaceutical preparations, namely, anti-inflammatories ANTI-Fibrotic properties; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperlipidemia, insulin resistance, metabolic syndrome , the endocrine system, namely growth and thyroid disorders, the musculo-skeletal system and the genitourinary system, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders, pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of skin disorders namely dermatitis, skin pigmentation diseases, eczema and psoriasis; pharmaceu...

Pharmaceutical research and development services; research and development of vaccines and medicines; scientific and technological services, namely, scientific research, analysis, and testing services in the fields of drug development, biotechnology, microbiology and molecular biology
immunitaire

General Information


Serial Number97166606
Word MarkIMMUNITAIRE
Filing DateFriday, December 10, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, July 18, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceuticals and pharmaceutical preparations, namely, anti-inflammatories ANTI-Fibrotic properties; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperlipidemia, insulin resistance, metabolic syndrome , the endocrine system, namely growth and thyroid disorders, the musculo-skeletal system and the genitourinary system, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders, pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of skin disorders namely dermatitis, skin pigmentation diseases, eczema and psoriasis; pharmaceutical products for the prevention and treatment of respiratory diseases including bronchiolitis obliterans and idiopathic pulmonary fibrosis
Translation of Words in MarkThe English translation of "IMMUNITAIRE" in the mark is "IMMUNE".
Goods and ServicesPharmaceutical research and development services; research and development of vaccines and medicines; scientific and technological services, namely, scientific research, analysis, and testing services in the fields of drug development, biotechnology, microbiology and molecular biology

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 15, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImmunitaire Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10016

Trademark Events


Event DateEvent Description
Tuesday, July 18, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, July 18, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, July 18, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, March 22, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 22, 2023NON-FINAL ACTION E-MAILED
Wednesday, March 22, 2023NON-FINAL ACTION WRITTEN
Friday, February 17, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 17, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 17, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 21, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 21, 2022NON-FINAL ACTION E-MAILED
Wednesday, September 21, 2022NON-FINAL ACTION WRITTEN
Monday, September 19, 2022ASSIGNED TO EXAMINER
Thursday, January 20, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, January 20, 2022ASSIGNED TO LIE
Sunday, January 16, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, December 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 14, 2021NEW APPLICATION ENTERED